1. Home
  2. UBX vs CDTG Comparison

UBX vs CDTG Comparison

Compare UBX & CDTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • CDTG
  • Stock Information
  • Founded
  • UBX 2009
  • CDTG 2012
  • Country
  • UBX United States
  • CDTG China
  • Employees
  • UBX N/A
  • CDTG N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • CDTG
  • Sector
  • UBX Health Care
  • CDTG
  • Exchange
  • UBX Nasdaq
  • CDTG NYSE
  • Market Cap
  • UBX 20.4M
  • CDTG 24.5M
  • IPO Year
  • UBX 2018
  • CDTG 2024
  • Fundamental
  • Price
  • UBX $0.99
  • CDTG $2.38
  • Analyst Decision
  • UBX Strong Buy
  • CDTG
  • Analyst Count
  • UBX 3
  • CDTG 0
  • Target Price
  • UBX $5.33
  • CDTG N/A
  • AVG Volume (30 Days)
  • UBX 148.7K
  • CDTG 469.6K
  • Earning Date
  • UBX 04-22-2025
  • CDTG 04-29-2025
  • Dividend Yield
  • UBX N/A
  • CDTG N/A
  • EPS Growth
  • UBX N/A
  • CDTG N/A
  • EPS
  • UBX N/A
  • CDTG 0.72
  • Revenue
  • UBX N/A
  • CDTG $31,432,824.00
  • Revenue This Year
  • UBX N/A
  • CDTG N/A
  • Revenue Next Year
  • UBX N/A
  • CDTG N/A
  • P/E Ratio
  • UBX N/A
  • CDTG $3.15
  • Revenue Growth
  • UBX N/A
  • CDTG N/A
  • 52 Week Low
  • UBX $0.85
  • CDTG $1.16
  • 52 Week High
  • UBX $3.10
  • CDTG $4.64
  • Technical
  • Relative Strength Index (RSI)
  • UBX 37.79
  • CDTG N/A
  • Support Level
  • UBX $0.91
  • CDTG N/A
  • Resistance Level
  • UBX $1.07
  • CDTG N/A
  • Average True Range (ATR)
  • UBX 0.09
  • CDTG 0.00
  • MACD
  • UBX 0.03
  • CDTG 0.00
  • Stochastic Oscillator
  • UBX 61.29
  • CDTG 0.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD

CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.

Share on Social Networks: